Stockreport

Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533's Proposed Mechanism of Action [Yahoo! Finance]

Molecular Partners AG - American Depositary Shares  (MOLN) 
PDF Results highlight MP0533-mediated T-cell activation and tumor regression, as well as cytokine release in AML models without systemic adverse effects Published data bu [Read more]